Episode
FDA Approves Label Supplement for iDose TR
- Podcast
- Eyewire News: The Podcast
- Published
- Jan 28, 2026
- Duration seconds
- 337
- Processing state
not_requested- Canonical source
- https://traffic.megaphone.fm/BMCL6362351584.mp3
Actions
POST https://stenobird.com/v1/public/podcasts/eyewire-news-the-podcast-7055536/episodes/fda-approves-label-supplement-for-idose-tr/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/fda-approves-label-supplement-for-idose-tr.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
The FDA approves a key label supplement for Glaukos’ iDoseTR; Nidek announces the European launch of a new open-field refraction system; and there have been several leadership changes announced during the first month of 2026. Learn more about your ad choices. Visit megaphone.fm/adchoices